Expect Nifty 50 to retest 26,000 in the near term, says Alpha Capital's founder

The broader market sentiment is positive, with expectations of Nifty 50 reaching new highs. This indicates a favorable environment for most sectors, including pharma, which has seen recent positive momentum.

Maintain a bullish bias on the overall market, with a focus on quality stocks across sectors. For pharma, look for companies with strong product pipelines and favorable regulatory outcomes.

For Indian markets, the practical takeaway is that this story carries a bullish read rather than a generic headline. Traders should judge it by actual market follow-through, not by narrative intensity alone.

Watch whether the market validates this read through price action, volume, and breadth. If the headline matters, the signal should show up in execution, not just in commentary.

• •Alpha Capital's founder expects Nifty 50 to retest 26,000 in the near term.
• •The positive outlook is attributed to stabilizing domestic flows and improving earnings.
• •Risks from crude oil prices are acknowledged as a potential headwind.
• •Risk flag: Potential volatility due to crude oil price fluctuations
• •Risk flag: Any unexpected global economic slowdowns